Support more young people in more countries
Increase support from 23,000 young people in 43 countries to 150,000 young people in 65 countries by 2030.
Improve type 1 diabetes health outcomes
Facilitate access to a wider range of management options. Expand support for local partners, including strengthening diabetes education. Increase access to skilled medical care through various initiatives.
Encourage local provision of type 1 diabetes care
Implement research and evidence-based advocacy initiatives that encourage country-level sustainability.
Vision 2030 has six key pillars
- 150,000 children and youth living with type 1 (T1D), type 2 and rare forms of diabetes are reached across 65 countries.
- Reach is expanded in high-population countries already served, including India, Ethiopia, Pakistan, Mexico, Nigeria and Bangladesh.
- Enrolment of new countries in need of support.
- Strengthen and expand logistic systems to ensure reliable provision of supplies.
- Improve access to analog insulin and modern insulin regimens.
- Increase provision of blood glucose test strips so young people are able to carry out more frequent daily measurements.
- All supported young people receive at least Intermediate Care.
- Explore ways of increasing access to skilled medical care through task-shifting and other initiatives.
- T1D health care professionals’ skills are sustainably strengthened through expert-delivered workshops, and training courses.
- Young people with T1D & their families have access to age- and culturally-appropriate diabetes education material and support through LFAC’s growing library of multilingual resources.
- Peer support networks are strengthened.
- Supported clinics have robust data.
- Supported centres have strengthened local capacity through well-functioning systems, patient registries, and standardized treatment guidelines.
- Epidemiological research is carried out on themes of incidence, prevalence, mortality, and types of diabetes. Access to care research is also studied through documentation of Universal Health Coverage progress, and cost-effectiveness analysis of T1D interventions.
- Country specific advocacy tools, derived from evidence-based research, are developed with local advocates for dissemination with respective national stakeholders.
- Governments are encouraged to provide sustainable access to T1D care and supplies to all young people in need.
"We aim to create a world where children with type 1 diabetes can thrive, no matter their situation."
Dr. Graham Ogle
It is only because of the generosity of individuals, charitable foundations, and in-kind and financial donations from industry, that we are able to independently support young people living with type 1 diabetes in under-resourced countries.
In particular for this expansion, we would like to thank Eli Lilly and Company, our long-term partner who initiated this project in recognition of the centenary of the discovery of insulin. Lilly has committed insulin for the expansion, including access to basal insulin, and coverage of the costs of packing and shipment. Lilly will also contribute substantially to other program costs for at least the first two years. The other major financial contributors are the Leona M. and Harry B. Helmsley Charitable Trust, JDRF, Diabetes NSW and Diabetes Australia.